vs

Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and CarParts.com, Inc. (PRTS). Click either name above to swap in a different company.

CarParts.com, Inc. is the larger business by last-quarter revenue ($120.4M vs $75.5M, roughly 1.6× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -9.8%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -8.6%).

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

Genuine Parts Company (GPC) is an American automotive and industrial parts distributor based in Atlanta, Georgia. Established by brothers Carlyle and Malcolm Fraser in 1928, the company has approximately 60,000 employees. In addition to the United States, GPC has operated in Australasia, Belgium, Canada, France, Germany, Mexico, the Netherlands, Poland, and the United Kingdom. GPC's subsidiaries include industrial parts distributor Motion as well as NAPA Auto Parts, which primarily sells part...

PBYI vs PRTS — Head-to-Head

Bigger by revenue
PRTS
PRTS
1.6× larger
PRTS
$120.4M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+37.5% gap
PBYI
27.7%
-9.8%
PRTS
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-8.6%
PRTS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PBYI
PBYI
PRTS
PRTS
Revenue
$75.5M
$120.4M
Net Profit
$-11.6M
Gross Margin
69.3%
33.2%
Operating Margin
22.7%
Net Margin
-9.6%
Revenue YoY
27.7%
-9.8%
Net Profit YoY
25.0%
EPS (diluted)
$0.26
$-0.82

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PBYI
PBYI
PRTS
PRTS
Q4 25
$75.5M
$120.4M
Q3 25
$54.5M
$127.8M
Q2 25
$52.4M
$151.9M
Q1 25
$46.0M
$147.4M
Q4 24
$59.1M
$133.5M
Q3 24
$80.5M
$144.8M
Q2 24
$47.1M
$144.3M
Q1 24
$43.8M
Net Profit
PBYI
PBYI
PRTS
PRTS
Q4 25
$-11.6M
Q3 25
$8.8M
$-10.9M
Q2 25
$5.9M
$-12.7M
Q1 25
$3.0M
$-15.3M
Q4 24
$-15.4M
Q3 24
$20.3M
$-10.0M
Q2 24
$-4.5M
$-8.7M
Q1 24
$-4.8M
Gross Margin
PBYI
PBYI
PRTS
PRTS
Q4 25
69.3%
33.2%
Q3 25
77.7%
33.1%
Q2 25
76.5%
32.8%
Q1 25
77.1%
32.1%
Q4 24
76.4%
32.5%
Q3 24
63.9%
35.2%
Q2 24
77.4%
33.5%
Q1 24
75.5%
Operating Margin
PBYI
PBYI
PRTS
PRTS
Q4 25
22.7%
Q3 25
17.6%
-7.9%
Q2 25
12.7%
-8.2%
Q1 25
8.7%
-10.3%
Q4 24
22.6%
-11.6%
Q3 24
27.4%
-6.9%
Q2 24
-4.6%
-6.0%
Q1 24
-5.3%
Net Margin
PBYI
PBYI
PRTS
PRTS
Q4 25
-9.6%
Q3 25
16.2%
-8.5%
Q2 25
11.2%
-8.4%
Q1 25
6.5%
-10.4%
Q4 24
-11.5%
Q3 24
25.2%
-6.9%
Q2 24
-9.6%
-6.0%
Q1 24
-11.0%
EPS (diluted)
PBYI
PBYI
PRTS
PRTS
Q4 25
$0.26
$-0.82
Q3 25
$0.17
$-0.19
Q2 25
$0.12
$-0.23
Q1 25
$0.06
$-0.27
Q4 24
$0.40
$-0.28
Q3 24
$0.41
$-0.17
Q2 24
$-0.09
$-0.15
Q1 24
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PBYI
PBYI
PRTS
PRTS
Cash + ST InvestmentsLiquidity on hand
$97.5M
$25.8M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$130.3M
$53.5M
Total Assets
$216.3M
$184.9M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PBYI
PBYI
PRTS
PRTS
Q4 25
$97.5M
$25.8M
Q3 25
$94.4M
Q2 25
$96.0M
Q1 25
$93.2M
Q4 24
$101.0M
Q3 24
$96.7M
Q2 24
$96.8M
Q1 24
$107.2M
Total Debt
PBYI
PBYI
PRTS
PRTS
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
PBYI
PBYI
PRTS
PRTS
Q4 25
$130.3M
$53.5M
Q3 25
$115.3M
$64.2M
Q2 25
$104.7M
$62.4M
Q1 25
$97.1M
$72.8M
Q4 24
$92.1M
$85.2M
Q3 24
$71.1M
$97.2M
Q2 24
$48.5M
$103.9M
Q1 24
$51.0M
Total Assets
PBYI
PBYI
PRTS
PRTS
Q4 25
$216.3M
$184.9M
Q3 25
$202.9M
$200.3M
Q2 25
$194.9M
$189.6M
Q1 25
$196.2M
$216.5M
Q4 24
$213.3M
$210.6M
Q3 24
$220.7M
$227.6M
Q2 24
$205.0M
$238.0M
Q1 24
$214.1M
Debt / Equity
PBYI
PBYI
PRTS
PRTS
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PBYI
PBYI
PRTS
PRTS
Operating Cash FlowLast quarter
$14.4M
Free Cash FlowOCF − Capex
$14.4M
FCF MarginFCF / Revenue
19.1%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PBYI
PBYI
PRTS
PRTS
Q4 25
$14.4M
Q3 25
$9.7M
$-6.4M
Q2 25
$14.1M
$-25.6M
Q1 25
$3.6M
$5.5M
Q4 24
$15.6M
$1.8M
Q3 24
$11.0M
$8.5M
Q2 24
$1.0M
$-3.6M
Q1 24
$11.2M
Free Cash Flow
PBYI
PBYI
PRTS
PRTS
Q4 25
$14.4M
Q3 25
$9.7M
$-8.3M
Q2 25
$14.1M
$-27.9M
Q1 25
$3.6M
$3.4M
Q4 24
$15.6M
$-631.0K
Q3 24
$11.0M
$4.9M
Q2 24
$1.0M
$-10.8M
Q1 24
FCF Margin
PBYI
PBYI
PRTS
PRTS
Q4 25
19.1%
Q3 25
17.7%
-6.5%
Q2 25
26.8%
-18.3%
Q1 25
7.7%
2.3%
Q4 24
26.4%
-0.5%
Q3 24
13.7%
3.4%
Q2 24
2.1%
-7.5%
Q1 24
Capex Intensity
PBYI
PBYI
PRTS
PRTS
Q4 25
0.0%
Q3 25
0.0%
1.5%
Q2 25
0.0%
1.5%
Q1 25
0.1%
1.4%
Q4 24
0.0%
1.8%
Q3 24
0.0%
2.5%
Q2 24
0.0%
4.9%
Q1 24
0.0%
Cash Conversion
PBYI
PBYI
PRTS
PRTS
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons